Scientifically, my expertise lies in the areas of cytokine actions; erythropoiesis & hematopoiesis; and progenitor cell biology. To date, ~80 major publications have been contributed; independent NIH funding has been in-place since 1987; and ~35 scientists have been trained and placed. Administratively, I previously directed Penn State’s Immunobiology Program. While at the Maine Medical Center Research Institute, I served as Director of the COBRE Center of Excellence in Stem & Progenitor Cell Biology and Regenerative Medicine (2005-2017) and as a member of the Internal Steering Committee for MMCRI’s Phase-III COBRE in Vascular Biology. Nationally, I serve frequently on NIH special emphasis and Center review panels, contribute to workshops, and have served as a full-member of NIH’s Study Section in Molecular and Cellular Hematology (and previously, as a regular member of HEM2 Study Section). I also review frequently for Nature Medicine, Science, Blood, NEJM, Experimental Hematology, and have worked in sponsored and collaborative programs with a number of biopharma entities (eg, GSK, Centocor, Amgen, Affymax, RW Johnson, Adeptrix, Cell Signaling Technology).
Ph.D., Zoology/Animal Biology, University of Massachusetts - Amherst
B.A., Colby College
Sickle Cell Disease
Signal Transduction (Sensory/Cellular)
BENG 620: Tissue Engineering
BMS 620: Tissue Eng Cell Culture Lab
INCO 590: Rsrch Exp/MCBS
INCO 790: Adv Rsrch Exp/MCBS
MCBS 905: Contemp Top Molec/Cell/Biomed
MCBS 997: Seminar
Wojchowski, D. (2018). Ineffective erythropoiesis of TET2 deficiency. Blood, 132(22), 2320-2321.